Evidence map›Paper›PMID 39514693›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2024

Associations of Abnormal Fluid Status, Plasma Sodium Disorders, and Low Dialysate Sodium with Mortality in Patients on Hemodialysis.

Jule Pinter, Bernard Canaud, Kaitlin J Mayne, Stefano Stuard, Ulrich Moissl, Jeroen Kooman, Kitty J Jager, Nicholas C Chesnaye, Brendan Smyth, Bernd Genser

Abstract readMulticenter Study
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jule PinterDivision of Nephrology, Department of Medicine, University Hospital Wuerzburg, Wuerzburg, Germany.ORCID 0009-0007-8261-2586
Bernard CanaudSchool of Medicine, University of Montpellier, Montpellier, France.ORCID 0000-0001-6854-2816
Kaitlin J MayneDivision of Nephrology, Department of Medicine, University of Glasgow, Glasgow, Scotland.ORCID 0000-0002-5695-0270
Stefano StuardFMC Germany, Global Medical Office, Bad Homburg, Germany.ORCID 0000-0002-9546-4507
Ulrich MoisslGlobal Research and Development, Bad Homburg, Germany.
Jeroen KoomanDivision of Nephrology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, Netherlands.
Kitty J JagerDepartment of Medical Informatics, European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry, Academic Medical Center, Amsterdam, The Netherlands.ORCID 0000-0003-0444-8569
Nicholas C ChesnayeDepartment of Medical Informatics, European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry, Academic Medical Center, Amsterdam, The Netherlands.ORCID 0000-0003-4883-9174
Brendan SmythNHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia.ORCID 0000-0003-1838-3348
Bernd GenserDivision of Nephrology, Department of Medicine, University Hospital Wuerzburg, Wuerzburg, Germany.ORCID 0000-0001-5787-0902

Funding

Deutsche Forschungsgemeinschaft, Royal Australasian College of Physicians, Flinders Medical Center Projektnr. 413657723
6 · The paper itself

Abstract

Background: Abnormal fluid and plasma sodium concentrations are established prognostic factors for patients on hemodialysis. However, the cumulative effects of abnormal salt and water and potential effect modifications and the effect of dialysate sodium remain incompletely understood. Methods: The study followed 68,196 patients on incident hemodialysis from 875 dialysis clinics in 25 countries over 10 years (2010–2020) investigating dose-response patterns between cumulative exposure time of fluid overload/depletion (measured by bioimpedance spectroscopy using the Fresenius Body Composition Monitor), abnormal plasma sodium levels, low dialysate sodium, and all-cause mortality. We calculated time-varying cumulative exposure (in months) of relative fluid overload (any degree; >7% or severe; >13 or >15% in women or men, respectively) and fluid depletion (<−7%), hypo- or hypernatremia (sodium <135 or >145 mmol/L, respectively), low dialysate sodium (≤138 mmol/L), and estimated hazard ratios for all-cause mortality using a multivariable Cox model. Results: Of 2,123,957 patient-months, 61% were spent in any degree of fluid overload, 4% in fluid depletion, 11% in hyponatremia, and 1% in hypernatremia. Any degree of fluid overload was associated with higher all-cause mortality (hazard ratio peak at 3.42 [95% confidence intervals, 3.12 to 3.75] relative to no exposure), and this association with all-cause mortality seemed to be stronger with severe fluid overload. The risk pattern associated with hyponatremia was approximately linear in the first four patient-months and then plateaued after the fourth patient-month. We did not observe effect modification between fluid overload and hyponatremia. Conclusions: Even mild fluid overload was associated with higher mortality in patients on hemodialysis. Whether more stringent fluid management results in clinical improvement requires further investigation.

Indexed as

Dialysis SolutionsHypernatremiaHyponatremiaKidney Failure, ChronicRenal DialysisSodiumWater-Electrolyte ImbalanceAgedFemaleHumansMaleMiddle AgedDialysis SolutionsSodiumfluid, electrolyte, and acid-base disordershemodialysis

Identifiers

PMID39514693
PMCPMC11556921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.